Lawrence Otto Klein - CBO & COO at CRISPR Therapeutics AG

Issuer-level insider activity

Role
Cbo & Coo
Issuer ticker
CRSP on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Lawrence Otto Klein since 16 Aug 2025

Reported holdings for Lawrence Otto Klein in CRISPR Therapeutics AG

Form 4 holding CBO & COO

CRISPR Therapeutics AG

Security class
Restricted Stock Units
Shares / value
12,500
Estimated value
Report date
16 Aug 2022
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount

Transaction history for Lawrence Otto Klein in CRISPR Therapeutics AG

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .